Eyewire+

This Week on EyewireTV: The Executive Director of The American Society of Cataract & Refractive Surgery (ASCRS) previews the upcoming annual meeting and discusses the most pressing issues facing ophthalmology. Watch here: ow.ly/xSA350YyVaH

Oculis' Privosegtor received EMA PRIME designation for optic neuritis, reinforcing its potential as a first-in-class neuroprotective therapy supported by phase 2 data: eyewire.news/news/oculis-se…

Ocugen has completed dosing ahead of schedule in its phase 2/3 GARDian3 trial for OCU410ST, a gene therapy targeting Stargardt disease. Interim data analysis is expected in Q3 2026: eyewire.news/news/ocugen-co…

Haag-Streit has reopened submissions for its 8th annual Slit Lamp Imaging Competition, inviting global eye care professionals to submit ophthalmic images and videos through July 30: ow.ly/AOmh50YExOq

Nanoscope Therapeutics received Orphan Drug Designation in Saudi Arabia for MCO-010, an optogenetic therapy targeting inherited retinal dystrophies causing severe vision loss: eyewire.news/news/nanoscope…

Tenpoint Therapeutics has launched Yuvezzi, the first dual-agent eye drop approved in the US for presbyopia treatment, improving near vision with once-daily dosing: eyewire.news/news/tenpoint-…

Johnson & Johnson will present data from two studies on its FDA-approved Tecnis PureSee IOL at ASCRS 2026 in Washington, DC, April 10-13. eyewire.news/news/new-tecni…

Glaukos will present its latest ophthalmic technologies and research at the ASCRS 2026 annual meeting, including a symposium on the new FDA-approved Epioxa corneal cross-linking: eyewire.news/news/glaukos-t…

This week on EyewireTV: A massive recall is announced for several store-brand eye drops; the FDA extends dosing intervals for Eylea HD in patients with Wet AMD and DME; and Bausch + Lomb launches its second full range of vision IOL in Europe. Watch more: ow.ly/1S0x50YFNBv

Alcon unveiled Clareon TruPlus, a next-gen monofocal and toric IOL, featuring enhanced design for increased depth of focus without sacrificing distance vision quality: eyewire.news/news/alcon-lau…

i-Lumen Scientific received FDA IDE approval to start US enrollment for its i-SIGHT2 trial, testing bioelectric stimulation therapy for intermediate to advanced dry AMD: eyewire.news/news/i-lumen-s…

Luminopia's FDA-cleared therapy shows durable vision improvements in children with amblyopia, with lower regression rates than patching and gains in severe cases, per new real-world data presented at AAPOS: eyewire.news/news/luminopia…

The National Eye Institute requests input for its 2026-2031 strategic plan, focusing on science, training, AI, health disparities, and innovative research methods: eyewire.news/news/national-…

A study in Ophthalmology Glaucoma shows Melbourne Rapid Fields (MRF) enables reliable home-based visual field testing for glaucoma with strong agreement to clinical standards: eyewire.news/news/testing-h…

An international meta-analysis of 25 trials shows 0.01% atropine reduces myopia progression by 37% in children but with significant variation across ethnic groups: eyewire.news/news/internati…

The FDA approved Eylea HD dosing intervals up to 20 weeks for wet AMD and DME patients with response after 1 year, reducing injections to 2-3 per year: eyewire.news/news/regeneron…

Latinos en Optometry introduced bilingual tools to enhance communication between eye care providers and Latino patients, addressing gaps in eye health outcomes and cultural barriers: eyewire.news/news/latinos-e…

Ray Therapeutics’ RTx-015 for retinitis pigmentosa received FDA RMAT designation, enabling closer collaboration and potential expedited review for this optogenetic gene therapy: eyewire.news/news/ray-thera…

Cure Blindness Project and The Fred Hollows Foundation partner to eliminate avoidable blindness in Rwanda and Laos by 2035, delivering 177,000 cataract surgeries and strengthening local eye care: eyewire.news/news/global-he…

Zeiss will unveil AI-powered surgical tools, digital platforms, and advanced analytics to enhance ophthalmic care at ASCRS 2026 in Washington, D.C: eyewire.news/news/zeiss-to-…

IDOC has launched easyvision, a private label contact lens portfolio by CooperVision, offering independent optometrists a cost-competitive option to retain contact lens sales: eyewire.news/news/idoc-laun…